Inducible nitric oxide synthase dimerization inhibitor prevents cardiovascular and renal morbidity in sheep with combined burn and smoke inhalation injury

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 6 54-6, 2003, Pages

  Enkhbaatar, Perenlei ^a   Murakami, Kazunori ^a   Shimoda, Katsumi ^a   Mizutani, Akio ^a   Traber, Lillian ^a   Phillips, Gary ^c   Parkinson, John ^c   Salsbury, John R ^a   Biondo, Nettie ^a   Schmalstieg, Frank ^a   Burke, Ann ^a   Cox, Robert ^a   Hawkins, Hal ^a   Herndon, David ^b   Traber, Daniel ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c BAYER AG   (Germany)

Author keywords

Heart; Kidney

Indexed keywords

BBS 2; HALOTHANE; KETAMINE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

AERATION; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DIMERIZATION; FEMALE; FLUID BALANCE; HEART INDEX; HEART STROKE VOLUME; HEMOCONCENTRATION; INJURY SCALE; INTENSIVE CARE; KIDNEY DYSFUNCTION; LABORATORY; LUNG BURN; LUNG FUNCTION; LUNG HEMODYNAMICS; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; SHEEP; TRACHEOSTOMY;

EID: 0344440844     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00055.2003     Document Type: Article

References (35)

1. Blasko E, Glaser CB, Devlin JJ, Xia W, Feldman RI, Polokoff MA, Phillips GB, Whitlow M, Auld DS, McMillan K, Ghosh S, Stuehr DJ, and Parkinson JF. Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors. J Biol Chem 277: 295-302, 2002.
2. Bowen BD, Bert JL, Gu X, Lund T, and Reed RK. Microvascular exchange during burn injury: III. Implications of the model. Circ Shock 28: 221-233, 1989.
3. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banerjee A, and Harken AH. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 27: 1309-1318, 1999.
4. Cohen RI, Huberfeld S, Genovese J, Steinberg HN, and Scharf SM. A comparison between the acute effects of nitric oxide synthase inhibition and fluid resuscitation on myocardial function and metabolism in entotoxemic dogs. J Crit Care 11: 27-36, 1996.
5. Dancey DR, Hayes J, Gomez M, Schouten D, Fish J, Peters W, Slutsky AS, and Stewart TE. ARDS in patients with thermal injury. Intensive Care Med 25: 1235-1236, 1999.
6. Demling R, LaLonde C, Youn YK, and Picard L. Effect of graded increases in smoke inhalation injury on the early systemic response to a body burn. Crit Care Med 23: 171-178, 1995.
7. Demling RH, Will JA, and Belzer FO. Effect of major thermal injury on the pulmonary microcirculation. Surgery 83: 746-751, 1978.
8. Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, Traber L, Phillips GB, Parkinson JF, Cox R, Hawkins H, Herndon D, and Traber D. The iNOS inhibitor, BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury. Am J Respir Crit Care Med 167: 1021-1026, 2003.
9. Feng Q, Lu X, Jones DL, Shen J, and Arnold JM. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104: 700-704, 2001.
10. Giroir BP, Horton JW, White DJ, McIntyre KL, and Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol Heart Circ Physiol 267: H118-H124, 1994.
11. Grover R, Zaccardelli D, Colice G, Guntupalli K, Watson D, and Vincent JL. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88). Crit Care Med 27: 913-922, 1999.
12. Habisch HJ, Gorren AC, Liang H, Venema RC, Parkinson JF, Schmidt K, and Mayer B. Pharmacological interference with dimerization of human neuronal nitric-oxide synthase expressed in adenovirus-infected DLD-1 cells. Mol Pharmacol 63: 682-689, 2003.
13. Hinder F, Booke M, Traber LD, and Traber DL. Nitric oxide and endothelial permeability. J Appl Physiol 83: 1941-1946, 1997.
14. Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, and Colardyn FA. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol 14: 1022-1030, 2003.
15. Joe EK, Schussheim AE, Longrois D, Maki T, Kelly RA, Smith TW, and Balligand JL. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide. J Mol Cell Cardiol 30: 303-315, 1998.
16. Karnik AM, Bashir R, Khan FA, and Carvounis CP. Renal involvement in the systemic inflammatory reaction syndrome. Ren Fail 20: 103-116, 1998.
17. McDonald MC, Izumi M, Cuzzocrea S, and Thiemermann C. A novel, potent and selective inhibitor of the activity of inducible nitric oxide synthase (GW274150) reduces the organ injury in hemorrhagic shock. J Physiol Pharmacol 53: 555-569, 2002.
18. McMillan K, Adler M, Auld DS, Baldwin JJ, Blasko E, Browne LJ, Chelsky D, Davey D, Dolle RE, Eagen KA, Erickson S, Feldman RI, Glaser CB, Mallari C, Morrissey MM, Ohlmeyer MH, Pan G, Parkinson JF, Phillips GB, Polokoff MA, Sigal NH, Vergona R, Whitlow M, Young TA, and Devlin JJ. Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc Natl Acad Sci USA 97: 1506-1511, 2000.
19. Moncada S and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
20. Mungrue IN, Gros R, You X, Pirani A, Azad A, Csont T, Schulz R, Butany J, Stewart DJ, and Husain M. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest 109: 735-743, 2002.
21. Navar PD, Saffle JR, and Warden GD. Effect of inhalation injury on fluid resuscitation requirements after thermal injury. Am J Surg 150: 716-720, 1985.
22. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, Brodsky S, and Goligorsky MS. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 281: F948-F957, 2001.
23. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471-1477, 1993.
24. 2+-indepndent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575-580, 1992.
25. Soejima K, Schmalstieg FC, Sakurai H, Traber LD, and Traber DL. Pathophysiological analysis of combined burn and smoke inhalation injuries in sheep. Am J Physiol Lung Cell Mol Physiol 280: L1233-L1241, 2001.
26. Soejima K, Traber LD, Schmalstieg FC, Hawkins H, Jodoin JM, Szabo C, Szabo E, Varig L, Salzman A, and Traber DL. Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury. Am J Respir Crit Care Med 163: 745-752, 2001.
27. Sozumi T. The role of nitric oxide in vascular permeability after a thermal injury. Ann Plast Surg 39: 272-277, 1997.
28. Squara P, Dhainaut JF, Artigas A, and Carlet J. Hemodynamic profile in severe ARDS: results of the European Collaborative ARDS Study. Intensive Care Med 24: 1018-1028, 1998.
29. Szabo C, Ferrer-Sueta G, Zingarelli B, Southan GJ, Salzman AL, and Radi R. Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 272: 9030-9036, 1997.
30. Szabolcs MJ, Sun J, Ma N, Albala A, Sciacca RR, Philips GB, Parkinson J, Edwards N, and Cannon PJ. Effects of selective inhibitors of nitric oxide synthase-2 dimerization on acute cardiac allograft rejection. Circulation 106: 2392-2396, 2002.
31. Traber DL, Traber LD, and Sakurai H. Pulmonary microvascular changes seen with acute lung injury role of the bronchial circulation. JPN J Burn Inj 24: 233-246, 2000.
32. Ungureanu-Longrois D, Balligand JL, Kelly RA, and Smith TW. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 27: 155-167, 1995.
33. Ware LB and Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
34. Winlaw DS, Smythe GA, Keogh AM, Schyvens CG, Spratt PM, and Macdonald PS. Nitric oxide production and heart failure. Lancet 345: 390-391, 1995.
35. Zhang L, Looney CG, Qi WN, Chen LE, Seaber AV, Stamler JS, and Urbaniak JR. Reperfusion injury is reduced in skeletal muscle by inhibition of inducible nitric oxide synthase. J Appl Physiol 94: 1473-1478, 2003.